 PHILADELPHIA, May 28, 2021 PRNewswire -- Ibere Pharmaceuticals NYSE: IBER the Company today announced that it received a notice on May 25, 2021 from the New York Stock Exchange the NYSE indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 the Quarterly Report with the Securities and Exchange Commission the SEC. The notice has no immediate effect on the listing of the Companys stock on the NYSE. 